El dimetilfumarato: de un fármaco antipsoriático a un prometedor antineuropático

• Autores: Enrique José Cobos del Moral
• Localización: Revista de la Sociedad Española del Dolor (SED), ISSN 1134-8046, Vol. 27, Nº. 2, 2020, págs. 74-75
• Idioma: español
• DOI: 10.20986/resed.2020.3805/2020
• Títulos paralelos:
  • Dimethyl fumarate: from an antipsoriatic drug to a promising antineuropathic drug
• Texto completo no disponible (Saber más ...)
• Referencias bibliográficas
  • Bomprezzi, R. (2015). Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther Adv Neurol Disord. 8....
  • Ayala-Fontánez, N,Soler, DC,McCormick, TS. (2016). Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 6. 7-32
  • Grace, PM,Gaudet, AD,Staikopoulos, V,Maier, SF,Hutchinson, MR,Salvemini, D. (2016). Nitroxidative Signaling Mechanisms in Pathological Pain....
  • Satoh, T,Okamoto, SI,Cui, J,Watanabe, Y,Furuta, K,Suzuki, M. (2006). Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic...
  • Kappos, L,Gold, R,Miller, DH,Macmanus, DG,Havrdova, E,Limmroth, V. (2008). Efficacy and safety of oral fumarate in patients with relapsing-remitting...
  • Patejdl, R,Zettl, UK. (2017). Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic...
  • Li, J,Ma, J,Lacagnina, MJ,Lorca, S,Odem, MA,Walters, ET. (2020). Oral Dimethyl Fumarate Reduces Peripheral Neuropathic Pain in Rodents via...
  • Fornasari, D. (2017). Pharmacotherapy for Neuropathic Pain: A Review. Pain Ther. 6. 25-33